Literature DB >> 35331658

Cardiovascular Imaging for Ischemic Heart Disease in Women: Time for a Paradigm Shift.

Patricia F Rodriguez Lozano1, Elona Rrapo Kaso2, Jamieson M Bourque3, Mohamed Morsy1, Angela M Taylor1, Todd C Villines1, Christopher M Kramer3, Michael Salerno4.   

Abstract

Heart disease is the leading cause of death among men and women. Women have a unique phenotype of ischemic heart disease with less calcified lesions, more nonobstructive plaques, and a higher prevalence of microvascular disease compared with men, which may explain in part why current risk models to detect obstructive coronary artery disease (CAD) may not work as well in women. This paper summarizes the sex differences in the functional and anatomical assessment of CAD in women presenting with stable chest pain and provides an approach for using multimodality imaging for the evaluation of suspected ischemic heart disease in women in accordance to the recently published American Heart Association/American College of Cardiology guidelines for the evaluation and diagnosis of chest pain. A paradigm shift in the approach to imaging ischemic heart disease women is needed including updated risk models, a more profound understanding of CAD in women where nonobstructive disease is more prevalent, and algorithms focused on the evaluation of ischemia with nonobstructive CAD and myocardial infarction with nonobstructive CAD.
Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiovascular disease; heart disease in women; imaging; ischemia

Mesh:

Year:  2022        PMID: 35331658      PMCID: PMC9355915          DOI: 10.1016/j.jcmg.2022.01.006

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  69 in total

1.  Meta-analysis of exercise testing to detect coronary artery disease in women.

Authors:  Y Kwok; C Kim; D Grady; M Segal; R Redberg
Journal:  Am J Cardiol       Date:  1999-03-01       Impact factor: 2.778

2.  Nonobstructive coronary artery disease and risk of myocardial infarction.

Authors:  Thomas M Maddox; Maggie A Stanislawski; Gary K Grunwald; Steven M Bradley; P Michael Ho; Thomas T Tsai; Manesh R Patel; Amneet Sandhu; Javier Valle; David J Magid; Benjamin Leon; Deepak L Bhatt; Stephan D Fihn; John S Rumsfeld
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

3.  Global Coronary Flow Reserve Measured During Stress Cardiac Magnetic Resonance Imaging Is an Independent Predictor of Adverse Cardiovascular Events.

Authors:  Raksha Indorkar; Raymond Y Kwong; Simone Romano; Brent E White; Richard C Chia; Michael Trybula; Kaleigh Evans; Chetan Shenoy; Afshin Farzaneh-Far
Journal:  JACC Cardiovasc Imaging       Date:  2018-11-05

4.  Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography.

Authors:  Masanao Naya; Venkatesh L Murthy; Viviany R Taqueti; Courtney R Foster; Josh Klein; Mariya Garber; Sharmila Dorbala; Jon Hainer; Ron Blankstein; Frederick Resnic; Marcelo F Di Carli
Journal:  J Nucl Med       Date:  2014-01-09       Impact factor: 10.057

5.  Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women: an effect of smaller chamber size.

Authors:  C L Hansen; D Crabbe; S Rubin
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

6.  Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial.

Authors:  Eileen M Handberg; C Noel Bairey Merz; Rhonda M Cooper-Dehoff; Janet Wei; Michael Conlon; Margaret C Lo; William Boden; Susan M Frayne; Todd Villines; John A Spertus; William Weintraub; Patrick O'Malley; Bernard Chaitman; Leslee J Shaw; Matthew Budoff; Andre Rogatko; Carl J Pepine
Journal:  Am Heart J       Date:  2021-03-18       Impact factor: 4.749

7.  Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial.

Authors:  Maros Ferencik; Thomas Mayrhofer; Daniel O Bittner; Hamed Emami; Stefan B Puchner; Michael T Lu; Nandini M Meyersohn; Alexander V Ivanov; Elizabeth C Adami; Manesh R Patel; Daniel B Mark; James E Udelson; Kerry L Lee; Pamela S Douglas; Udo Hoffmann
Journal:  JAMA Cardiol       Date:  2018-02-01       Impact factor: 14.676

Review 8.  Coronary Microvascular Dysfunction: Clinical Considerations and Noninvasive Diagnosis.

Authors:  Thomas H Schindler; Vasken Dilsizian
Journal:  JACC Cardiovasc Imaging       Date:  2019-04-12

9.  Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry.

Authors:  Sharmila Dorbala; Marcelo F Di Carli; Rob S Beanlands; Michael E Merhige; Brent A Williams; Emir Veledar; Benjamin J W Chow; James K Min; Michael J Pencina; Daniel S Berman; Leslee J Shaw
Journal:  J Am Coll Cardiol       Date:  2012-12-05       Impact factor: 24.094

10.  Natural History of Patients With Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study.

Authors:  Harmony R Reynolds; Michael H Picard; John A Spertus; Jesus Peteiro; Jose Luis Lopez Sendon; Roxy Senior; Mohammad C El-Hajjar; Jelena Celutkiene; Michael D Shapiro; Patricia A Pellikka; Dennis F Kunichoff; Rebecca Anthopolos; Khaled Alfakih; Khaled Abdul-Nour; Michel Khouri; Leonid Bershtein; Mark De Belder; Kian Keong Poh; John F Beltrame; James K Min; Jerome L Fleg; Yi Li; David J Maron; Judith S Hochman
Journal:  Circulation       Date:  2021-06-01       Impact factor: 39.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.